
The Compute 100: Patrick Bowen, CEO of Neurophos
Today's guest is Patrick Bowen, CEO of Neurophos. Patrick's path into chips started at age nine, when a neighbor taught him to build radios from Radio Shack kits and handed him a college EE textbook, which Patrick read cover to cover, homework included. He later double-majored in physics and EE, then did his PhD at Duke under David R. Smith, the physicist who built the first real invisibility cloak out of metamaterials. As Patrick puts it, "there's no market for cloaks." But the trick behind them, engineering materials smaller than the wavelength of light, became the seed for Neurophos. The company shrinks optical modulators 10,000x smaller than what's on the market, packing a million onto a fingernail-sized chip instead of one the size of a card table. That density powers Neurophos's T100 optical processing unit, which aims for 50x more compute per wafer. Neurophos closed a $110M Series A backed by Microsoft's M12 earlier this year. We're thrilled to have Patrick on the podcast for a conversation about the physics case for optical over digital compute, why he's targeting the prefill half of inference over decode, and what it will take to make photonics real at data center scale. Patrick: https://www.linkedin.com/in/ptbowen/ The Compute 100 is led by Brian Schechter and Gaby Lorenzi, compute-focused investors at Primary. Primary is a pre-seed and seed-stage venture firm that backs founders building across markets including compute, industrials, healthcare and vertical AI. With $1.6B AUM and a 60+ person operating team, Primary delivers unparalleled support to teams across recruiting, finance, GTM, and brand. Primary's compute portfolio includes Etched, The Biological Computing Company, Haiqu, and Atero (acquired by Crusoe). Primary: https://www.primary.vc/ Follow us on X (https://x.com/thecompute100) and check out our daily newsletter (https://newsletter.thecompute100.com/). This podcast is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Nothing discussed in this podcast constitutes investment, legal, tax, or accounting advice, or a recommendation to make any investment. Any views expressed are as of the date of recording, are subject to change, and may include forward-looking statements that involve risks and uncertainties.







